ATE536413T1 - Auf knochen als ziel gerichtete alkalische phosphatase, kits und verwendungsverfahren dafür - Google Patents

Auf knochen als ziel gerichtete alkalische phosphatase, kits und verwendungsverfahren dafür

Info

Publication number
ATE536413T1
ATE536413T1 AT08757088T AT08757088T ATE536413T1 AT E536413 T1 ATE536413 T1 AT E536413T1 AT 08757088 T AT08757088 T AT 08757088T AT 08757088 T AT08757088 T AT 08757088T AT E536413 T1 ATE536413 T1 AT E536413T1
Authority
AT
Austria
Prior art keywords
amino acid
alkaline phosphatase
kits
methods
bone targeted
Prior art date
Application number
AT08757088T
Other languages
English (en)
Inventor
Philippe Crine
Guy Boileau
Thomas Loisel
Isabelle Lemire
Pierre Leonard
Robert Heft
Hal Landy
Original Assignee
Enobia Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enobia Pharma Inc filed Critical Enobia Pharma Inc
Application granted granted Critical
Publication of ATE536413T1 publication Critical patent/ATE536413T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/03Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03001Alkaline phosphatase (3.1.3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/33Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/025Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a parvovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Adornments (AREA)
  • Cereal-Derived Products (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT08757088T 2007-05-11 2008-05-12 Auf knochen als ziel gerichtete alkalische phosphatase, kits und verwendungsverfahren dafür ATE536413T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91758907P 2007-05-11 2007-05-11
PCT/CA2008/000923 WO2008138131A1 (en) 2007-05-11 2008-05-12 Bone targeted alkaline phosphatase, kits and methods of use thereof

Publications (1)

Publication Number Publication Date
ATE536413T1 true ATE536413T1 (de) 2011-12-15

Family

ID=40001639

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08757088T ATE536413T1 (de) 2007-05-11 2008-05-12 Auf knochen als ziel gerichtete alkalische phosphatase, kits und verwendungsverfahren dafür

Country Status (25)

Country Link
US (1) US20100297119A1 (de)
EP (3) EP2158319B1 (de)
JP (1) JP5732603B2 (de)
AT (1) ATE536413T1 (de)
AU (1) AU2008250945B2 (de)
BR (2) BRPI0811198B8 (de)
CA (1) CA2687001C (de)
CY (1) CY2016005I2 (de)
DE (1) DE202008018131U1 (de)
DK (3) DK2158319T3 (de)
ES (3) ES2471915T3 (de)
FR (1) FR16C0007I2 (de)
HR (1) HRP20140416T1 (de)
HU (2) HUE031655T2 (de)
IL (1) IL202057A0 (de)
LT (1) LTC2368999I2 (de)
LU (1) LU92976I2 (de)
ME (1) ME01828B (de)
NL (1) NL300798I1 (de)
NO (1) NO2016002I1 (de)
PL (3) PL2158319T4 (de)
PT (3) PT2662448T (de)
RS (1) RS53302B (de)
SI (2) SI2662448T1 (de)
WO (1) WO2008138131A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE055861T2 (hu) 2004-04-21 2021-12-28 Alexion Pharma Inc Csontbejuttató konjugátumok és azok alkalmazási módszere fehérjék csonthoz kötéséhez
US20070081984A1 (en) 2005-10-11 2007-04-12 Shunji Tomatsu Compositions and methods for treating hypophosphatasia
US8784833B2 (en) * 2006-06-27 2014-07-22 Saint Louis University Prenatal enzyme replacement therapy for hypophosphatasia
MX367012B (es) 2007-06-01 2019-08-02 Univ Maryland Agentes de union al receptor de la region constante fc de inmunoglobulina.
WO2011113027A2 (en) 2010-03-12 2011-09-15 Synageva Biopharma Corp Npp1 fusion proteins
BR112012027765A2 (pt) * 2010-04-30 2019-09-24 Enobia Pharma Inc métodos, composições e kits para tratamento de distúrbios de mineralização da matriz.
AU2011282579B2 (en) 2010-07-28 2014-10-23 Gliknik Inc. Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions
US9266939B2 (en) 2010-12-27 2016-02-23 Alexion Pharmaceuticals, Inc. Compositions comprising natriuretic peptides and methods of use thereof
SG11201401605QA (en) * 2011-10-19 2014-09-26 Alexion Pharma Holding Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
EP2885320A4 (de) 2012-08-20 2016-04-06 Gliknik Inc Moleküle mit antigenbindender und polyvalenter fc-gamma-rezeptorbindender aktivität
PE20161442A1 (es) * 2014-01-24 2017-01-12 Am-Pharma B V Proteinas quimericas tipo fosfatasa alcalina
WO2016007873A1 (en) 2014-07-11 2016-01-14 The Regents Of The University Of Michigan Compositions and methods for treating craniosynostosis
CA2967851C (en) 2014-12-05 2024-02-27 Alexion Pharmaceuticals, Inc. Treating seizure with recombinant alkaline phosphatase
AU2016211447B2 (en) 2015-01-28 2021-09-23 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
FI3325011T6 (fi) 2015-07-24 2023-05-11 Ihmisen proteiinifragmenttien fuusioproteiineja järjestyksenmukaisesti multimerisoitujen, paremmin komplementtia sitovien immunoglobuliini-fc-koostumusten muodostamiseksi
EP3337894A1 (de) * 2015-08-17 2018-06-27 Alexion Pharmaceuticals, Inc. Herstellung von alkalischen phosphatasen
JP6868617B2 (ja) * 2015-09-28 2021-05-12 アレクシオン ファーマシューティカルズ, インコーポレイテッド 低ホスファターゼ血症の組織非特異的アルカリホスファターゼ(tnsalp)酵素補充療法に有効な投薬計画の特定
US11400140B2 (en) 2015-10-30 2022-08-02 Alexion Pharmaceuticals, Inc. Methods for treating craniosynostosis in a patient
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
WO2017171871A1 (en) * 2016-04-01 2017-10-05 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
KR20220162816A (ko) * 2016-04-01 2022-12-08 알렉시온 파마슈티칼스, 인코포레이티드 알칼리성 포스파타아제로 근육 약화의 치료
WO2017173395A1 (en) * 2016-04-01 2017-10-05 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
US10988744B2 (en) 2016-06-06 2021-04-27 Alexion Pharmaceuticals, Inc. Method of producing alkaline phosphatase
US11034775B2 (en) 2016-06-07 2021-06-15 Gliknik Inc. Cysteine-optimized stradomers
EP3474886B1 (de) 2016-06-27 2021-08-04 Alexion Pharmaceuticals, Inc. Verfahren zur behandlung von hypophosphatasie bei kindern und jugendlichen
WO2018035420A1 (en) 2016-08-18 2018-02-22 Alexion Pharmaceuticals, Inc. Methods for treating tracheobronchomalacia
WO2018102616A1 (en) * 2016-11-30 2018-06-07 Purdue Research Foundation Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
JP7519774B2 (ja) 2016-12-09 2024-07-22 グリックニック インコーポレイテッド 多価fc化合物を用いる炎症性疾患の治療方法
KR102729723B1 (ko) 2016-12-09 2024-11-15 글리크닉 인코포레이티드 다합체화 스트라도머인 gl-2045의 제조 최적화
US20220348977A1 (en) * 2017-03-09 2022-11-03 Alexion Pharmaceuticals, Inc. Glycoprotein manufacturing process
JP2020512363A (ja) * 2017-03-31 2020-04-23 アレクシオン ファーマシューティカルズ, インコーポレイテッド 成人及び青年における低ホスファターゼ症(hpp)を治療する方法
WO2019067502A1 (en) 2017-09-27 2019-04-04 Alexion Pharmaceuticals, Inc. METHODS FOR IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING RECOMBINANT ECTO-NUCLEOTIDE PYROPHOSPHATASE / PHOSPHODIESTERASE
EP3737750B1 (de) 2018-01-09 2024-06-05 Theriva Biologics, Inc. Alkalische phosphatasemittel zur behandlung von entwicklungsstörungen des nervensystems
JP7214962B2 (ja) * 2018-01-17 2023-01-31 東ソー株式会社 アルカリホスファターゼ高発現動物細胞
ES3032290T3 (en) 2018-03-20 2025-07-16 Theriva Biologics Inc Intestinal alkaline phosphatase formulations
WO2019183209A1 (en) 2018-03-20 2019-09-26 Synthetic Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
JP2021519590A (ja) * 2018-03-30 2021-08-12 アレクシオン ファーマシューティカルズ, インコーポレイテッド 糖タンパク質の製造
CN110499284A (zh) * 2018-05-17 2019-11-26 西安组织工程与再生医学研究所 Wnt信号通路激活剂在制备治疗基因ALPL敲除小鼠牙硬组织矿化异常产品中的应用
US20210214408A1 (en) 2018-05-30 2021-07-15 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
WO2020033867A2 (en) 2018-08-10 2020-02-13 Alexion Pharmaceuticals, Inc. Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
AU2020270046B2 (en) 2019-05-06 2026-02-05 Theriva Biologics, Inc. Alkaline phosphate-based oncology treatments
JP7796645B2 (ja) * 2019-12-09 2026-01-09 アレクシオン ファーマシューティカルズ, インコーポレイテッド アルカリホスファターゼポリペプチド及びその使用方法
EP4084819A1 (de) 2020-01-03 2022-11-09 The United States of America, as represented by the Secretary, Department of Health and Human Services Lokal verabreichtes tnap zum fördern der periodontalen gesundheit
KR20230117327A (ko) * 2020-09-03 2023-08-08 어빈 에스.와이. 첸 가용성 알칼리성 포스파타제 작제물 및 가용성 알칼리성 포스파타제 작제물을 인코딩하는 폴리뉴클레오티드를 포함하는 발현 벡터
KR102571967B1 (ko) * 2021-01-21 2023-08-30 주식회사 마라나노텍코리아 Alp 측정용 바이오 센서
CA3173631A1 (en) 2021-02-12 2022-08-18 Walter C. Voegtli Alkaline phosphatase polypeptides and methods of use thereof
US20260027233A1 (en) * 2022-08-31 2026-01-29 University Of Utah Research Foundation Gja1-20k compositions and methods for mitigating ischemia-reperfusion injury

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008A (en) * 1850-01-08 Improvement in alloys for points of lightning-rods
ES2249761T3 (es) 1993-06-24 2006-04-01 Advec Inc. Vectores de adenovirus para terapia genica.
SK283703B6 (sk) 1993-10-25 2003-12-02 Canji, Inc. Rekombinantný adenovírusový vektor a jeho použitie
US7252989B1 (en) 1994-04-04 2007-08-07 Board Of Regents, The University Of Texas System Adenovirus supervector system
ATE360082T1 (de) 1999-11-16 2007-05-15 Genzyme Corp Vektoren und transgene mit regulatorischen elementen zur genverabreichung in leber
US6808905B2 (en) 2001-05-14 2004-10-26 Cell Genesys, Inc. Lentiviral vectors encoding clotting factors for gene therapy
CA2433479A1 (en) 2002-07-22 2004-01-22 F. Hoffmann-La Roche Ag Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof
HUE055861T2 (hu) 2004-04-21 2021-12-28 Alexion Pharma Inc Csontbejuttató konjugátumok és azok alkalmazási módszere fehérjék csonthoz kötéséhez
US20070081984A1 (en) * 2005-10-11 2007-04-12 Shunji Tomatsu Compositions and methods for treating hypophosphatasia
WO2006002203A2 (en) 2004-06-23 2006-01-05 Genzyme Corporation Methods and compositions for the treatment of polycystic diseases
WO2006039480A2 (en) * 2004-09-29 2006-04-13 The Burnham Institute For Medical Research Tissue non-specific alkaline phosphate (tnap): a therapeutic target for arterial calcification
MX2007006524A (es) 2004-12-01 2007-06-22 Genzyme Corp Metodos para el suministro dirigido de material genetico al higado.

Also Published As

Publication number Publication date
PT2662448T (pt) 2017-03-29
PT2158319E (pt) 2012-03-06
JP5732603B2 (ja) 2015-06-10
HK1191372A1 (en) 2014-07-25
JP2010526543A (ja) 2010-08-05
DK2368999T3 (da) 2014-05-26
EP2158319B1 (de) 2011-12-07
LU92976I2 (en) 2016-04-11
CY2016005I1 (el) 2016-08-31
ES2619332T3 (es) 2017-06-26
HK1141047A1 (en) 2010-10-29
PT2368999E (pt) 2014-05-26
HK1162589A1 (en) 2012-08-31
SI2368999T1 (sl) 2014-07-31
NL300798I2 (de) 2016-03-16
LTC2368999I2 (lt) 2017-09-25
HUS1600005I1 (hu) 2016-02-29
FR16C0007I2 (fr) 2017-01-27
EP2662448B1 (de) 2016-12-21
WO2008138131A9 (en) 2009-08-06
BRPI0811198B8 (pt) 2021-05-25
PL2158319T4 (pl) 2016-04-29
PL2158319T3 (pl) 2012-05-31
PL2662448T3 (pl) 2017-07-31
CA2687001C (en) 2019-02-12
BRPI0811198A2 (pt) 2014-10-21
BR122019000505A2 (pt) 2021-12-14
BR122019000505B1 (pt) 2022-01-18
EP2662448A1 (de) 2013-11-13
HUE031655T2 (hu) 2017-07-28
BRPI0811198B1 (pt) 2021-03-09
AU2008250945A2 (en) 2009-12-24
NL300798I1 (de) 2016-03-16
AU2008250945B2 (en) 2013-12-12
EP2158319A1 (de) 2010-03-03
AU2008250945A1 (en) 2008-11-20
RS53302B (sr) 2014-08-29
DK2158319T3 (da) 2012-03-19
SI2662448T1 (sl) 2017-05-31
EP2368999B1 (de) 2014-03-12
US20100297119A1 (en) 2010-11-25
WO2008138131A1 (en) 2008-11-20
PL2368999T3 (pl) 2014-08-29
LTPA2016004I1 (lt) 2016-02-25
NO2016002I2 (no) 2016-02-02
CY2016005I2 (el) 2016-08-31
EP2368999A1 (de) 2011-09-28
DK2662448T3 (en) 2017-03-20
EP2158319A4 (de) 2010-07-21
ES2471915T3 (es) 2014-06-27
CA2687001A1 (en) 2008-11-20
WO2008138131A4 (en) 2008-12-31
IL202057A0 (en) 2011-08-01
FR16C0007I1 (de) 2016-04-15
NO2016002I1 (no) 2016-02-02
ES2380546T3 (es) 2012-05-16
ME01828B (me) 2014-12-20
DE202008018131U1 (de) 2011-12-30
BRPI0811198A8 (pt) 2018-08-14
HRP20140416T1 (hr) 2014-06-20

Similar Documents

Publication Publication Date Title
ATE536413T1 (de) Auf knochen als ziel gerichtete alkalische phosphatase, kits und verwendungsverfahren dafür
ATE461990T1 (de) Zusammensetzung für die gewebepflege
CR7017A (es) Carboxamidas como fungicidas en agricultura
ATE490987T1 (de) Härter für niedrigtemperaturanwendungen
CR10303A (es) "derivados de quinolina y su uso com pesticidas"
BR0312915A (pt) Piridinas e pirimidinas substituìdas com 4-trifluormetilpirazolila
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
NI200700287A (es) Inhibidores de la fosfolipasa a2 citosolica
EA201101149A1 (ru) Новые трицианобораты
BR0110999A (pt) Misturas de adesivos aquosos
AR027575A1 (es) Benzoilciclohexenonas substituidas
BRPI0509116A (pt) 3-amino-2-tiometil-benzoilpirazóis ativos como herbicida
DK2084198T3 (da) Beklædningssammensætning
PT1268469E (pt) N-(heterociclil)benzeno ou piridino-sulfonamidas como agentes anti-tromboticos eanti-coagulantes
ITMI20050265U1 (it) Indumento intimo ovvero capo d'abbigliamento integrante tale indumento intimo
ITMI20031790A1 (it) Antagonistici abiotici dell'eparina.
BR0208732A (pt) Derivados de benzoilciclohexandionas e seu uso como herbicidas
CY1115263T1 (el) Αλκαλικη φωσφαταση στοχευμενη στα οστα, κιτ και μεθοδοι χρησης αυτων
GT200300191A (es) Dibencenoxazepinas
SE0601728L (sv) Arrangemang för att förhindra en ljudalstring
CR7434A (es) N-aril-2-oxazolidinona-5- carboxamidas y sus derivados